SOLACEL Trademark

Trademark Overview

On Monday, October 29, 2018, a trademark application was filed for SOLACEL with the United States Patent and Trademark Office. The USPTO has given the SOLACEL trademark a serial number of 88173558. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 4, 2021. This trademark is owned by Sun Pharma Global FZE. The SOLACEL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of Drug Delivery Technology for others for controlled and continuous delivery of drugs
solacel

General Information

Serial Number88173558
Word MarkSOLACEL
Filing DateMonday, October 29, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 4, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 9, 2019

Trademark Statements

Goods and ServicesDevelopment of Drug Delivery Technology for others for controlled and continuous delivery of drugs

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, November 13, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSun Pharma Global FZE
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDubai
AE
Party NameSun Pharma Global FZE
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDubai
AE

Trademark Events

Event DateEvent Description
Monday, January 4, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 4, 2021ABANDONMENT - NO USE STATEMENT FILED
Friday, June 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 3, 2020EXTENSION 2 GRANTED
Wednesday, June 3, 2020EXTENSION 2 FILED
Wednesday, June 3, 2020TEAS EXTENSION RECEIVED
Wednesday, November 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 25, 2019EXTENSION 1 GRANTED
Monday, November 25, 2019EXTENSION 1 FILED
Monday, November 25, 2019TEAS EXTENSION RECEIVED
Tuesday, June 4, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 9, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 9, 2019PUBLISHED FOR OPPOSITION
Wednesday, March 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 25, 2019ASSIGNED TO LIE
Friday, February 8, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 7, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, February 7, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 7, 2019EXAMINERS AMENDMENT E-MAILED
Thursday, February 7, 2019EXAMINERS AMENDMENT -WRITTEN
Monday, February 4, 2019ASSIGNED TO EXAMINER
Tuesday, November 13, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 1, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

solacel delivery continuous drugs controlled technology drug development others